Project Grant R21ES037250
Award Date
6/11/25
Completion Date
5/31/27
Dollars Obligated
$226K
Funding Federal Agency
Office of the Director
Awarding Federal Agency
National Institute of Environmental Health Sciences
Federal Grant Program
93.310
Assistance Type
Project Grant
Place of Performance
Wisconsin, USA
Similar Awards
The University of Wisconsin System was awarded a $1,199,999 Project Grant from the Office of Naval Research (ONR) under the Basic and Applied Scientific Research program (CFDA 12.300). The grant, awarded on November 1, 2024, will fund the development of a "Translational Injury Model System for Identifying Neuroimaging and Neural Signaling-Based Biomarkers for Early Detection and Mitigation of Mild Traumatic Brain Injury." This research aims to advance the understanding and early...
This Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) provides $235,500.00 to Rutgers, The State University of New Jersey to investigate how electrophilic fatty acids can reduce lung damage caused by chlorine gas exposure. The project aims to pre-screen various electrophilic fatty acid compounds to identify the most effective inhibitors of pro-inflammatory macrophage activation, which contributes to...
This $600,000 Project Grant, awarded by the Office of Naval Research under the Basic and Applied Scientific Research program (CFDA 12.300), supports multiscale and multiplexed biochemical analysis of tissues and cells to investigate brain injury upon directed pulsed electromagnetic radiation exposure. The award, with a performance period from November 1, 2024 to October 31, 2028, will be carried out by the University of Wisconsin System, specifically the University of Wisconsin-Madison. This...
The University of Wisconsin System was awarded a $750,000 Project Grant under the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) to develop the PRC-210 therapeutic for rapid limb stabilization and protection from ischemia-reperfusion injury. The award period runs from September 1, 2024 to August 31, 2026. As part of this grant, the University of Wisconsin - Madison's Research and Sponsored Programs division will conduct research to optimize the...
This $445,500 Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) will fund research by the University of Alabama at Birmingham (UAB) to investigate the role of proteolytic extracellular vesicles (EVs) in mediating chronic lung injury after exposure to chlorine (Cl2) or bromine (Br2) gas. The key objectives are to determine how PMN-derived EVs containing neutrophil elastase (NE) contribute to the...
This $777,500 federal Project Grant was awarded by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) program. The grant will fund a 3-year (June 1, 2025 to May 31, 2028) research project at the University of Wisconsin-Madison to conduct a multiomic analysis of liquid biopsies for biomarker discovery and therapeutic targeting. The research aims to transform healthcare for military service members and the broader public by investigating innovative...
This Project Grant award from the National Institutes of Health's Trans-NIH Research Support program (CFDA 93.310) will provide $482,242 to The Medical College of Wisconsin, Inc. to conduct research on the mechanisms of mustard gas toxicity in the retina using a minipig model. The project aims to characterize the in vivo clinical, structural, and functional changes in the retina of a minipig model exposed to mustard gas, and identify molecular targets involved in retinal degenerative...
The University of Wisconsin System was awarded a $1,712,026 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "LOCAL SLEEP IN THE WAKING BRAIN: A NOVEL TARGET FOR COGNITIVE FATIGUE", will fund research at the University of Wisconsin - Madison campus between June 1, 2024 and May 31, 2028. The research aims to investigate a novel approach to addressing cognitive fatigue in military personnel. As a...
The University of Wisconsin System was awarded a $995,076 project grant by the U.S. Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to support the development of new agents for the treatment of hormone receptor positive and HER2 positive breast cancer. The grant was awarded on Dec 15, 2023 and is scheduled for completion on Dec 14, 2026. As part of this project, the University of Wisconsin System has sub-awarded funding to Loyola University of...
The Department of the Navy's Office of Naval Research awarded the University of Wisconsin-Madison a $223,256 Project Grant under the Basic and Applied Scientific Research program (CFDA 12.300). The grant supports research into neuronal signaling signatures of neuroinflammatory pathways following traumatic brain injury. The three-year award beginning November 1, 2022 will fund University of Wisconsin-Madison researchers to analyze how neuroinflammation impacts neuronal signaling after traumatic...